Geriatric assessment-identified deficits in older cancer patients with normal performance status

Oncologist

Volumn 20, Issue 4, 2015, Pages 379-385

  Jolly, Trevor A ^a,b   Deal, Allison M ^a   Nyrop, Kirsten A ^a   Williams, Grant R ^a   Pergolotti, Mackenzi ^c   Wood, William A ^a   Alston, Shani M ^a   Gordon, Brittaney Belle E ^b   Dixon, Samara A ^a   Moore, Susan G ^d   Chris Taylor, W ^e   Messino, Michael ^f   Muss, Hyman B ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d Rex Hematology/Oncology Associates   (United States)

^e New Bern Cancer Center   (United States)

^f Cancer Care of Western North Carolina   (United States)

Author keywords

Cancer; Geriatric assessment; Older; Performance status

Indexed keywords

AGED; ARTICLE; ASSESSMENT OF HUMANS; BLESSED ORIENTATION MEMORY CONCENTRATION TEST; BODY MASS; BODY WEIGHT DISORDER; BREAST CANCER; CANCER PATIENT; COGNITION; COMORBIDITY; FEMALE; FIVE ITEM MENTAL HEALTH INDEX; GERIATRIC ASSESSMENT; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOMES SURVEY; MENTAL HEALTH; PHYSICAL ACTIVITY, CAPACITY AND PERFORMANCE; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SOCIAL BEHAVIOR; SOCIAL SUPPORT; TIMED UP AND GO; CLINICAL TRIAL; MULTIVARIATE ANALYSIS; NEOPLASMS; PROCEDURES; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GERIATRIC ASSESSMENT; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; NEOPLASMS; SOCIAL BEHAVIOR; SOCIAL SUPPORT;

EID: 84927666199     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0247     Document Type: Article

References (57)

1. SEER stat fact sheets: All cancer sites. Available at http://seer. cancer. gov/statfacts/html/all. html. Accessed February 20, 2015.
2. U. S. Census Bureau projections show a slower growing, older, more diverse nation a half century from now. Available at http://www. census. gov/newsroom/releases/archives/population/cb12-243. html. Accessed February 20, 2015.
3. Smith BD, Smith GL, Hurria A et al. Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758-2765.
4. Hurria A, Naylor M, Cohen HJ. Improving the quality of cancer care in an aging population: Recommendations from an IOM report. JAMA 2013; 310: 1795-1796.
5. Mohile SG, Magnuson A. Comprehensive geriatric assessment in oncology. Interdiscip Top Gerontol 2013; 38: 85-103.
6. Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: Understanding frailty and the geriatric assessment. CA Cancer J Clin 2010; 60: 120-132.
7. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-M156.
8. Repetto L, Fratino L, Audisio RA et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: AnItalianGroup for Geriatric Oncology Study. J Clin Oncol 2002; 20: 494-502.
9. Extermann M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Contr 2003; 10: 463-468.
10. Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press, 1949: 191-205.
11. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984; 2: 187-193.
12. Crooks V, Waller S, Smith T et al. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 1991; 46: M139-M144.
13. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980; 45: 2220-2224.
14. Blagden SP, Charman SC, Sharples LD et al. Performance status score: Do patients and their oncologists agree? Br J Cancer 2003; 89: 1022-1027.
15. Loprinzi CL, Laurie JA, Wieand HS et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 1994; 12: 601-607.
16. Schnadig ID, Fromme EK, Loprinzi CL et al. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer 2008; 113: 2205-2214.
17. Dajczman E, Kasymjanova G, Kreisman H et al. Should patient-rated performance status affect treatment decisions in advanced lung cancer? J Thorac Oncol 2008; 3: 1133-1136.
18. Cohen HJ, Feussner JR, Weinberger M et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002; 346: 905-912.
19. Kázmierska J. Assessment of health status in elderly patients with cancer. Rep Pract Oncol Radiother 2012; 18: 44-48.
20. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. JClin Oncol 2007; 25: 1824-1831.
21. Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 1981; 36: 428-434.
22. Katz S, Downs TD, Cash HR et al. Progress in development of the index of ADL. Gerontologist 1970; 10: 20-30.
23. Stafford RS, Cyr PL. The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer 1997; 80: 1973-1980.
24. Hurria A, Cirrincione CT, Muss HB et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011; 29: 1290-1296.
25. Clough-GorrKM, Stuck AE, Thwin SS et al. Older breast cancer survivors: Geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol 2010; 28: 380-386.
26. Hoppe S, RainfrayM, FonckMet al. Functional decline in older patients with cancer receiving firstline chemotherapy. J Clin Oncol 2013; 31: 3877-3882.
27. Naeim A, Reuben D. Geriatric syndromes and assessment in older cancer patients. Oncology (Williston Park) 2001; 15: 1567-1577, 1580; discussion 1581, 1586, 1591.
28. Hurria A, GuptaS, ZaudererMet al. Developing a cancer-specific geriatric assessment: A feasibility study. Cancer 2005; 104: 1998-2005.
29. Hurria A, Lichtman SM, Gardes J et al. Identifying vulnerable older adults with cancer: Integrating geriatric assessment intooncology practice. JAm Geriatr Soc 2007; 55: 1604-1608.
30. Williams GR, Deal A, Jolly T et al. Feasibility of geriatric assessment in community oncology clinics. J Geriatr Oncol 2014; 5: 245-251.
31. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in communitydwelling older adults using the Timed Up & Go Test. Phys Ther 2000; 80: 896-903.
32. Podsiadlo D, Richardson S. The timed "Up & Go": A test of basic functional mobility for frail elderly persons. J AmGeriatr Soc 1991; 39: 142-148.
33. Kawas C, Karagiozis H, Resau L et al. Reliability of the Blessed Telephone Information-Memory-Concentration test. J Geriatr Psychiatry Neurol 1995; 8: 238-242.
34. Katzman R, Brown T, Fuld P et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983; 140: 734-739.
35. Stewart AL, Kamberg CJ. Physical functioning measures. In: Stewart AL, Ware JE Jr, eds. Measuring Functioningand Well-Being: The Medical Outcomes Survey. Durham, NC: Duke University Press, 1992: 86-101.
36. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991; 32: 705-714.
37. Sherbourne CD. Social functioning: Social activity limitations measure. In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being: The Medical Outcomes Study. Durham, NC: Duke University Press, 1991: 173-181.
38. Rumpf H-J, Meyer C, Hapke U et al. Screening for mental health: Validity of the MHI-5 using DSMIV Axis I psychiatric disorders as gold standard. Psychiatry Res 2001; 105: 243-253.
39. Trainor K, Mallett J, Rushe T. Age related differences in mental health scale scores and depression diagnosis: Adult responses to the CIDISF and MHI-5. J Affect Disord 2013; 151: 639-645.
40. Kelly MJ, Dunstan FD, Lloyd K et al. Evaluating cutpoints for the MHI-5 and MCS using the CGQ-12: A comparison of five different methods. BMC Psychiatry 2008; 8: 10.
41. Landi F, Onder G, Gambassi G et al. Body mass index and mortality among hospitalized patients. Arch Intern Med 2000; 160: 2641-2644.
42. Teno J, Kiel DP, Mor V. Multiple stumbles: A risk factor for falls in community-dwelling elderly. A prospective study. J Am Geriatr Soc 1990; 38: 1321-1325.
43. Lees J, Chan A. Polypharmacy in elderly patients with cancer: Clinical implications and management. Lancet Oncol 2011; 12: 1249-1257.
44. Extermann M, Overcash J, Lyman GH et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16: 1582-1587.
45. Newman AB, Yanez D, Harris T et al. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001; 49: 1309-1318.
46. Soubeyran P, Fonck M, Blanc-Bisson C et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012; 30: 1829-1834.
47. Injury prevention & control: Data & statistics (WISQARSTM). Available at http://www. cdc. gov/injury/wisqars/.
48. CuijpersP, Smits N, Donker T et al. Screening for mood and anxiety disorders with the five-item, the three-item, and the two-item Mental Health Inventory. Psychiatry Res 2009; 168: 250-255.
49. Diagnostic and statistical manual of mental disorders. 4th ed. Text rev. Washington, DC: American Psychiatric Association, 2000.
50. Patnaik JL, Byers T, Diguiseppi C et al. The influence ofcomorbiditiesonoverall survivalamong older women diagnosed with breast cancer. J Natl Cancer Inst 2011; 103: 1101-1111.
51. Marinello R, Marenco D, Roglia D et al. Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients. Arch Gerontol Geriatr 2009; 48: 222-226.
52. Maas HAJ-HM, Janssen-Heijnen ML, Olde Rikkert MG et al. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 2007; 43: 2161-2169.
53. Holmes CE, Muss HB. Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin 2003; 53: 227-244.
54. Shavers VL, BrownML, Potosky AL et al. Race/ethnicity and the receipt of watchfulwaiting for the initial management of prostate cancer. J Gen Intern Med 2004; 19: 146-155.
55. Geraci JM, Escalante CP, Freeman JL et al. Comorbid disease and cancer: The need for more relevant conceptual models in health services research. J Clin Oncol 2005; 23: 7399-7404.
56. Meyerhardt JA, Catalano PJ, Haller DG et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003; 21: 433-440.
57. Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000; 35: 147-154.